Bide Pharmatech competes as a supplier of pharmaceutical intermediates and molecular building blocks for drug discovery research, developing, producing, and selling intermediates while providing custom synthesis. It classifies these building blocks by molecular structure into benzene-ring, heterocyclic, and aliphatic categories. It serves key stages of new drug research, including drug target discovery, hit-compound screening, lead-compound discovery, synthesis and optimization, and drug candidate discovery.
Customers use the company's products in research and production across life sciences, organic chemistry, materials science, analytical chemistry, and other disciplines, with sales reaching customers worldwide. It can produce at laboratory, pilot, and industrial scale to meet customer production needs. The firm has established partnerships with pharmaceutical research organizations in China and abroad.
